Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting the IL-17-T(H)17 pathway.

Literature DB >> 25549584

Targeting the IL-17-T(H)17 pathway.

Hilary S Bartlett¹, Ryan P Million¹.

Abstract

Entities: Gene

Mesh：

Substances：

Year: 2015 PMID： 25549584 DOI： 10.1038/nrd4518

Source DB: PubMed Journal: Nat Rev Drug Discov ISSN： 1474-1776 Impact factor: 84.694

× No keyword cloud information.

2 in total

Review 1. Biologic fatigue in psoriasis.

Authors: Ethan C Levin; Rishu Gupta; Gabrielle Brown; Mona Malakouti; John Koo
Journal: J Dermatolog Treat Date: 2013-08-27 Impact factor: 3.359

Review 2. Targeting IL-17 and TH17 cells in chronic inflammation.

Authors: Pierre Miossec; Jay K Kolls
Journal: Nat Rev Drug Discov Date: 2012-10 Impact factor: 84.694

2 in total

27 in total

Review 1. Th17 cells in depression.

Authors: Eléonore Beurel; Jeffrey A Lowell
Journal: Brain Behav Immun Date: 2017-08-03 Impact factor: 7.217

2. TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response.

Authors: Ming-Fen Ho; James N Ingle; Tim Bongartz; Krishna R Kalari; Paul E Goss; Lois E Shepherd; Taisei Mushiroda; Michiaki Kubo; Liewei Wang; Richard M Weinshilboum
Journal: Mol Pharmacol Date: 2017-06-14 Impact factor: 4.436

3. Expression Profile of Genes Related to the Th17 Pathway in Macrophages Infected by Leishmania major and Leishmania amazonensis: The Use of Gene Regulatory Networks in Modeling This Pathway.

Authors: Leilane Oliveira Gonçalves; Andrés F Vallejo Pulido; Fernando Augusto Siqueira Mathias; Alexandre Estevão Silvério Enes; Maria Gabriela Reis Carvalho; Daniela de Melo Resende; Marta E Polak; Jeronimo C Ruiz
Journal: Front Cell Infect Microbiol Date: 2022-06-14 Impact factor: 6.073

4. Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicity.

Authors: Joachim Hanna; Flavio Beke; Louise M O'Brien; Chrysa Kapeni; Hung-Chang Chen; Valentina Carbonaro; Alexander B Kim; Kamal Kishore; Timon E Adolph; Mikkel-Ole Skjoedt; Karsten Skjoedt; Marc de la Roche; Maike de la Roche
Journal: Nat Commun Date: 2022-07-14 Impact factor: 17.694

Review 5. Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.

Authors: Maria Gabriella Matera; Clive Page; Paola Rogliani; Luigino Calzetta; Mario Cazzola
Journal: Drugs Date: 2016-09 Impact factor: 9.546

6. Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis.

Authors: Racquel Domingo-Gonzalez; Shibali Das; Kristin L Griffiths; Mushtaq Ahmed; Monika Bambouskova; Radha Gopal; Suhas Gondi; Marcela Muñoz-Torrico; Miguel A Salazar-Lezama; Alfredo Cruz-Lagunas; Luis Jiménez-Álvarez; Gustavo Ramirez-Martinez; Ramón Espinosa-Soto; Tamanna Sultana; James Lyons-Weiler; Todd A Reinhart; Jesus Arcos; Maria de la Luz Garcia-Hernandez; Michael A Mastrangelo; Noor Al-Hammadi; Reid Townsend; Joan-Miquel Balada-Llasat; Jordi B Torrelles; Gilla Kaplan; William Horne; Jay K Kolls; Maxim N Artyomov; Javier Rangel-Moreno; Joaquín Zúñiga; Shabaana A Khader
Journal: JCI Insight Date: 2017-10-05

Targeting the IL-17-T(H)17 pathway.

Review 1. Biologic fatigue in psoriasis.

Review 2. Targeting IL-17 and TH17 cells in chronic inflammation.

Review 1. Th17 cells in depression.

2. TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response.

3. Expression Profile of Genes Related to the Th17 Pathway in Macrophages Infected by Leishmania major and Leishmania amazonensis: The Use of Gene Regulatory Networks in Modeling This Pathway.

4. Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicity.

Review 5. Therapeutic Monoclonal Antibodies for the Treatment of Chronic Obstructive Pulmonary Disease.

6. Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis.

Review 7. Therapeutic antibodies that target inflammatory cytokines in autoimmune diseases.

8. [A systematic review of anti-interleukin-17 antibody in the treatment of plaque psoriasis].

Review 9. Breast Milk and Solid Food Shaping Intestinal Immunity.

Review 10. Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis.